Quantification of large scale DNA organization for predicting prostate cancer recurrence.

about

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

Item

http://www.wikidata.org/entity/Q48516686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@en

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@nl

type

Item

label

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@en

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@nl

prefLabel

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@en

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@nl

P1476

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

@en

P2093

Andrea Lo

http://www.w3.org/2001/XMLSchema#string

Branko Palcic

http://www.w3.org/2001/XMLSchema#string

Colin Collins

http://www.w3.org/2001/XMLSchema#string

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Jagoda Korbelik

http://www.w3.org/2001/XMLSchema#string

Laden Fazli

http://www.w3.org/2001/XMLSchema#string

Malcolm Hayes

http://www.w3.org/2001/XMLSchema#string

Martin Gleave

http://www.w3.org/2001/XMLSchema#string

Mira Keyes

http://www.w3.org/2001/XMLSchema#string

Sarah Keyes

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia.

Prostate-cancer mortality at 11 years of follow-up.

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

Prostate cancer screening in Primary Health Care: the current state of affairs.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions

Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology.

Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

P304

1164-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.A.23287

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martial Guillaud

Calum E MacAulay

P577

2017-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194951

http://www.w3.org/2001/XMLSchema#string